Compare NBTX & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | FLNC |
|---|---|---|
| Founded | 2003 | 2018 |
| Country | France | United States |
| Employees | N/A | 1670 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2018 | 2021 |
| Metric | NBTX | FLNC |
|---|---|---|
| Price | $39.70 | $13.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 17 |
| Target Price | ★ $36.00 | $15.71 |
| AVG Volume (30 Days) | 103.7K | ★ 7.8M |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,262,830,000.00 |
| Revenue This Year | $58.17 | $51.23 |
| Revenue Next Year | N/A | $21.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.09 | $6.60 |
| 52 Week High | $57.14 | $33.51 |
| Indicator | NBTX | FLNC |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 35.26 |
| Support Level | $38.89 | $11.88 |
| Resistance Level | $42.40 | $13.92 |
| Average True Range (ATR) | 2.49 | 1.19 |
| MACD | 0.10 | -0.08 |
| Stochastic Oscillator | 64.01 | 5.12 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.